Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Coenzyme Q 10

PreclinicalSmall molecule

UUniversitas Diponegoro

2

Indications

4

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Muscle PainCompleted

Coenzyme Q10Completed

Muscle PainPreclinical

Completed

Coenzyme Q10Preclinical

Completed

Timeline

Expected Milestones

Q3 2027

Phase 2/3Not yet recruiting

Toxicity

NCT07476443

Clinical

Trials by Indication[1]

Coenzyme Q102 trials

Coenzyme Q10 in Older Athletes Treated With Statin Medications

Completed·—·Phase 4·NCT01026311·20 enrolled

Effect Supplementation of COenzyme Q10 in Acute STEMI Underwent PPCI

Completed·UUniversitas Diponegoro·N/A·NCT06661018·46 enrolled

Toxicity1 trial

Renoprotective Role of Vitamin C and Coenzyme Q10 in Nephrotoxicity

Not yet recruiting·—·Phase 2/3·NCT07476443·75 enrolled

Muscle Pain1 trial

Does Coenzyme Q 10 Supplementation Reduce Muscle Pain Caused by Statins? (Cholesterol Lowering Medications)

Completed·HHadassah Medical Organization·N/A·NCT00716612·37 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Coenzyme Q 10. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Coenzyme Q 10 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Coenzyme Q 10. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Universitas Diponegoro company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversitas Diponegoro

Related News